Multiple myeloma is a rare and incurable type of cancer that affects cells in the bone marrow called plasma cells. An EU-funded project is using revolutionary cell technology to tackle multiple myeloma, developing a viable and commercially attractive treatment for it and other rare diseases.

An EU-funded project has developed a blood-cell analysis device that helps doctors and scientists better understand the causes and mechanics of rare forms of anaemia - potentially speeding up the development of new treatments adjusted to the needs of patients with these diseases.

Finnish firm Mobidiag has received a EUR 15-million loan extended by the InnovFin Infectious Diseases Finance Facility under the EU's Horizon 2020 programme. Provided by the European Investment Bank, the loan is accelerating the development of fast, life-saving tests for small laboratories.

The widespread adoption of magnetic resonance imaging (MRI) revolutionised clinical medicine, and the revolution has not stopped. Scientists in an EU-funded project are exploring ways to make MRIs even more effective - aiming to help patients get the best possible treatment through early disease detection.

Pancreatic cancer is a leading cause of cancer-related death. Technology from an EU-funded project could guide surgery to remove pancreatic tumours and target post-operative radiotherapy to cancerous cells, improving patients' chances of survival.

An EU-funded project is using slime mould to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market. The devices can also be used for citizen science applications.

Coronary heart disease is a leading cause of death worldwide, but identifying those at high risk remains difficult. EU-funded research has helped identify new biomarkers that will improve diagnosis and lead to new and better treatment options.

A wide variety of conditions can affect the brain, complicating patients' interaction with the world around them. Although the psychosocial difficulties faced by people living with such illnesses are often underestimated, an EU-funded project has revealed they are often similar across a wider range of mental disorders. Thus, more general and cross-cutting approaches can help to mitigate a wide range of common disease-associated psychosocial problems. Greater awareness of this should help improve patient care.

A clinical study led by EU-funded researchers is administering a promising Parkinson's drug to the first human patients - delivering it directly to the brain using an innovative drug device.

EU-funded researchers have shown that a daily medical nutrition drink can help to stabilise everyday cognitive and functional performance in elderly people.

The conference is organised by the Centre of Excellence in Computational Biomedicine (CompBioMed), aimed at nurturing and promoting the uptake and exploitation of high performance computing within the biomedical modelling community.

Located at the Institute of Engineering and Technology London: Savoy Place, the CompBioMed Conference 2019 will combine a venue with innovative catering and spectacular views of the River Thames with an exciting programme of relevant symposia and world-renowned plenary and invited speakers, proposed and secured by our International Organising Committee.

In addition to the conference, we have an associated event at the London Science Museum.

With the principle of 'better health for all' at its core, Horizon 2020's Societal Challenge 1 (Health, demographic change and wellbeing) focuses on:

•  personalised health and care •  infectious diseases and improving global health •  innovative and sustainable health systems •  decoding the role of the environment (including climate change) for health and wellbeing •  digital transformation •  cybersecurity in health and care

Horizon 2020 Societal Challenge 1 work programme for 2020 (2020 Health calls) will be expected to offer calls for proposals with an overall budget of about €650 million. Funding opportunities will be presented at the Open Info Day on 3 July.

Registrationss will open shortly on this website.

Related to the Open Info Day, but as a separate event, the EU-funded project Health-NCP-Net 2.0 is organizing a free of charge Partnering Event on 4 July in Brussels which is meant to assist you in finding the right project partners for the upcoming 2020 Health calls.

Registration via the NCP website will open shortly.

Biomedical imaging has revolutionised medicine, granting doctors a window into miniscule molecular and cellular processes inside the body. An EU-funded project helped to expand the view, developing innovative radiochemistry concepts and techniques that could lead to earlier diagnosis of diseases - saving lives.

EU-funded researchers have conducted the first successful trials of an innovative gene therapy to treat a rare and debilitating metabolic disorder, using a small and innocuous virus as a carrier for genetic information to correct the functioning of liver and muscle cells.

The EU-funded ENACT project has used a combination of computer simulation and experimental validation to develop more efficient and sustainable chemical processes for the energy and pharmaceutical sectors - good for the environment, health, and the EU's competitiveness.

Multi-country clinical trials have significant advantages but the practicalities of setting them up and managing them can be daunting. An EU-funded project involving 23 countries contributed to the ongoing development of an infrastructure that offers hands-on support and boosts Europe's capacity for life-saving research.

Many modern drugs are less effective than they could be because they are blocked by the body's own defences. EU-funded researchers have devised ways to bypass these barriers to get drugs to where they are needed.

Wearable sensors for at-home rehabilitation or detection of an irregular heartbeat... An EU-funded project is training students to transform healthcare in today's hyperconnected world, helping them harness the power of technology to keep patients out of hospital, cut costs and even save lives.

Using advances in electronics and software, a team of EU-funded researchers is developing new ways to control upper limb prosthetics. Their goal is to improve and facilitate the everyday lives of amputees.

Your response to a drug depends, in part, on your genetic make-up. An EU-funded project is developing a system to help doctors take into account a patient's genotype when prescribing treatment, for safer and more effective therapy.